We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Acute Gastroenteritis May Lead to Heart Disease

By LabMedica International staff writers
Posted on 09 Dec 2010
People who become infected with Escherichia coli have a higher risk of subsequently developing hypertension, heart disease, and kidney problems. More...


Individuals who have become infected with E. coli 0157:H7 and/or Campylobacter and suffered from acute gastroenteritis may have an increased risk of chronic diseases associated with high blood pressure and renal impairment.

An assessment was made at Victoria Hospital, (London, Ontario, Canada), of 4,561 people who had been exposed to a tainted municipal water system in May 2000. The water had been infected with Campylobacter and E. coli 0157:H7 bacteria. The long-term health of 1,977 individuals who had developed gastroenteritis was evaluated as 1,067 of them became ill with acute gastroenteritis, and 378 sought help from a physician. Of the 131 stool samples tested for pathogens, 19% were positive for E. coli O157:H7, 19% were positive for Campylobacter, and 1.5% showed coinfection. This prospective cohort study was conducted from 2002 until 2008.

Structural and functional renal impairment were defined as microalbuminuria (albumin:creatinine ratio greater than 2.0 mg/mmol in men and more than 2.8 mg/mmol in women) and estimated glomerular filtration rate less than 60 mL/min/1.73 m2, respectively. Two classifications of renal impairment were analyzed: the presence of either indicator of renal impairment and the presence of both indicators.

The investigators discovered that those who had developed gastroenteritis symptoms had a 1.3 higher risk of developing hypertension (high blood pressure) compared to those who had not become infected. Renal impairment (kidney problem) risk was 3.4 times higher, and the chances of having a cardiovascular event, such as stroke or heart attack were 2.1 times higher. Recent research suggests that the presence of both structural and functional renal impairment is a stronger predictor of mortality, cardiovascular morbidity, and renal decline than either structural or functional renal impairment alone.

The authors concluded that their findings underline the need for following up individual cases of food or water poisoning by E. coli O157:H7 to prevent or reduce silent progressive vascular injury. These long-term consequences emphasize the importance of ensuring safe food and water supply as a cornerstone of public health.

The study was published November 17, 2010, in the British Medical Journal.

Related Links:

Victoria Hospital


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.